Featured Research

from universities, journals, and other organizations

Catching the early spread of breast cancer

Date:
March 19, 2014
Source:
American Chemical Society (ACS)
Summary:
When cancer spreads, it becomes even more deadly. It moves with stealth and can go undetected for months or years. But a new technology that uses “nano-flares” has the potential to catch these tumor cells early. Scientist present the latest advances in nano-flare technology as it applies to the detection of metastatic breast cancer cells.

When cancer spreads from one part of the body to another, it becomes even more deadly. It moves with stealth and can go undetected for months or years. But a new technology that uses "nano-flares" has the potential to catch these lurking, mobilized tumor cells early on. Today, scientists presented the latest advances in nano-flare technology as it applies to the detection of metastatic breast cancer cells.

The report was one of more than 10,000 at the 247th National Meeting & Exposition of the American Chemical Society (ACS). The meeting is taking place here through Thursday.

"We've taken perhaps the world's most important molecule, DNA, rearranged it into a spherical shape and modified it to detect specific molecules inside cells. These structures naturally enter cells and light up when they detect disease-causing molecules," said Chad Mirkin, Ph.D., who is collaborating with C. Shad Thaxton, M.D., Ph.D., to develop the new technology. "We're seeing if we can use nano-flares to create a new type of breast cancer diagnostic, and the early results are remarkable. Nano-flares could completely and radically change how we diagnose breast cancer."

Earlier is better when it comes to cancer detection, but sometimes, by the time a patient notices symptoms and visits a doctor, the first tumor has already spread from its original location in the body to another. It has undergone "metastasis," a state that causes many deaths related to cancer. Cancer took the lives of more than 8 million people worldwide in 2012.

To catch breast cancer -- and possibly other types of cancers -- earlier, the research groups built upon Mirkin's ongoing program that kicked off in the 1990s with the invention of "spherical nucleic acids" (SNAs). SNAs are usually made out of a gold nanoparticle core covered with densely packed, short strands of DNA.

"We thought that if we could get large amounts of nucleic acids to go inside cells, we could manipulate and measure things inside cells," said Mirkin, of Northwestern University. "Most people said we were wasting our time, but then out of curiosity, we put these particles in cell culture. Not only did we find that they go in, they went in better than any material known to man."

Taking advantage of their ability to enter cells easily, Mirkin's group set out to turn SNAs into a diagnostic tool -- the nano-flare. Recently, he and Thaxton designed these particles, which enter circulating healthy and unhealthy cells in blood samples, but light up only inside breast cancer cells.

"Nano-flares can detect just a few cancer cells in a sea of healthy cells," Mirkin said. "That's important because when cancer spreads, only a few cells may break off from the original tumor and go into the bloodstream. An added bonus of these particles is that scientists may be able to sample the live cancerous cells and figure out what therapies they might respond to."

The groups have successfully tested the nano-flares' ability to identify metastatic breast cancer cells in blood samples from animals and are currently experimenting with human samples.

"If the work pans out, a commercial diagnostic test could be available in the near future," Thaxton said.

In addition to diagnostics, it turns out nano-flares can be used to perform other unique and valuable tasks.

"Nano-flares represent the only way to measure genetic content in live cells," Mirkin said. This kind of real-time observation could be useful in many areas of research and could lead to clinical advances. For example, using nano-flares, scientists can see how drugs target different genes. This would help them develop better treatments. One company, Millipore, has already commercialized the particles for use in research labs under the name SmartFlaresTM and offers more than 1,200 variations.

For the breast cancer detection work, Mirkin and Thaxton recognized funding from the Centers of Cancer Nanotechnology Excellence and the National Cancer Institute.


Story Source:

The above story is based on materials provided by American Chemical Society (ACS). Note: Materials may be edited for content and length.


Cite This Page:

American Chemical Society (ACS). "Catching the early spread of breast cancer." ScienceDaily. ScienceDaily, 19 March 2014. <www.sciencedaily.com/releases/2014/03/140319124526.htm>.
American Chemical Society (ACS). (2014, March 19). Catching the early spread of breast cancer. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2014/03/140319124526.htm
American Chemical Society (ACS). "Catching the early spread of breast cancer." ScienceDaily. www.sciencedaily.com/releases/2014/03/140319124526.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins